Literature DB >> 30581033

[Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe].

K Chassain1, A Croué2, E Blanchard3, S Leclerc-Mercier4, J Fischer5, L Martin6.   

Abstract

BACKGROUND: Herein we present a case of palmoplantar keratoderma (PPK) in a young adopted girl of Chinese origin living in France. OBSERVATION: The patient, aged six years, had presented transgressive PPK since birth, as well as erythema progressing in congestive inflammatory episodes, palmoplantar hyperhidrosis and progressive characteristics (moderate hyperkeratosis in areas of rubbing other than the palms and soles, namely the elbows and knees). Histopathological examination of a skin biopsy revealed a thick epidermis with lengthening and thickening of crests. The epithelium displayed a thick granular layer. Electron microscopy showed hyperorthokeratosis with hypergranulosis and loss of lamellar structure of the keratinosomes, as well as cleavage between corneocytes. Molecular studies showed the presence of two composite heterozygous mutations of the SERPINB7 gene, enabling a diagnosis of Nagashima-type PPK (NPPK) to be made. DISCUSSION: NPPK is an autosomal recessive disease caused by a mutation in the SERPINB7, a member of the superfamily of serine protease inhibitors. It was described by Nagashima in 1977 with molecular characterisation by Kubo following in 2013. It is the most widespread form of PPK in Asia (with a prevalence of 1.2/10,000 in Japan and 3.1/10,000 in China). It is distinguished from the other PPKs in terms of transgressive soft hyperkeratosis, inflammatory episodes and hyperhidrosis, as well as by its non-progressive nature. In the present case, while the clinical presentation was characteristic, diagnosis was only made thanks to sequencing of a panel of over 50 genes responsible for PPK. The disease is effectively little-known in Europe. This study highlights the increasing importance of diagnostic investigation methods involving the use of gene panels.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Kératodermie palmo-plantaire de type Nagashima; Nagashima-type palmoplantar keratoderma

Mesh:

Substances:

Year:  2018        PMID: 30581033     DOI: 10.1016/j.annder.2018.11.005

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  3 in total

1.  Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion.

Authors:  Eran Cohen-Barak; Wassim Azzam; Jennifer L Koetsier; Nada Danial-Farran; Moran Barcan; Maysa Hriesh; Morad Khayat; Natalia Edison; Judith Krausz; Chen Gafni-Amsalem; Akiharu Kubo; Lisa M Godsel; Michael Ziv; Stavit Allon-Shalev
Journal:  Exp Dermatol       Date:  2021-08-17       Impact factor: 4.511

Review 2.  Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.

Authors:  Chao Huang; Yali Yang; Xingyu Huang; Zongke Zhou
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

3.  Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.

Authors:  Tong Xiao; Yan Liu; Tian Wang; Junru Ren; Yumin Xia; Xiaopeng Wang
Journal:  J Dermatol       Date:  2022-02-17       Impact factor: 3.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.